Scarica l'app Stockscreener
1.72
6.83%
0.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Cel-Sci Corp. Borsa (CVM) Ultime notizie
CEL-SCI Corp (CVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CEL-SCI Corp (CVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CEL-SCI Corp (CVM) Institutional Confidence - TradingKey
CEL-SCI Corp (CVM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CEL-SCI Corp (CVM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CEL-SCI Corp (CVM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CVM|CEL-SCI Corp|Price:1.180|Chg%:+0.010 - TradingKey
CEL-SCI Corp (CVM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CEL-SCI Corp (CVM) Balance Sheet - TradingKey
TradingKey - TradingKey
CEL-SCI Corp (CVM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
$1.155 | Cel-Sci Corporation (CVM) Stock Price Today - Binance
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month - Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
CEL-SCI launches confirmatory study for head and neck cancer drug - Investing.com
CEL-SCI (CVM) Initiates Global Study for Multikine in Head and N - GuruFocus
Cancer drug Multikine heads into 212-patient global trial for head and neck tumors - Stock Titan
Why Did CEL-SCI Stock Plunge After Its Latest Offering - Kavout | AI
CVMCel-Sci Corp Latest SEC Filings - Finviz
Form DEF 14A CEL-SCI CORPORATION For: 2 July By Investing.com - Investing.com Nigeria
[ARS] CEL SCI CORP SEC Filing - Stock Titan
Equity plans and pay votes at CEL-SCI (NYSE: CVM) 2026 annual meeting - Stock Titan
Form 4 CEL-SCI Corp For: 1 July By Investing.com - Investing.com UK
CEL SCI CORP (CVM) Chief Scientific Officer receives 2,307-share stock grant - Stock Titan
CEL SCI CORP (CVM) CFO receives 4,125-share stock grant in Form 4 - Stock Titan
CEL-SCI (CVM) CEO Kersten granted 5,192 common shares at $1.04 - Stock Titan
CVM: CEL-SCI Partners with Saudi Amarox for Multikine Launch - GuruFocus
CEL-SCI signs distribution deal with Saudi Amarox for Multikine - Investing.com
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care - The Joplin Globe
CEL-SCI and Saudi Amarox seal Multikine pact at BIO 2026 - Stock Titan
CVM Q4 2024 Earnings: Narrower-Than-Expected Loss as Cel-Sci Advances PipelineProfitability Analysis - dars.gov.et
CVM stock sinks in pre-market trading after announcing second equity raise for its cancer drug in just over a month - MSN
BRIEF-CEL-SCI Announces Closing Of Offering - Dailyhunt
CEL-SCI Corp (CVM) Valuation: PE, PB & Fair Value Analysis - TradingKey
CEL-SCI Corporation Announces $2.5 Million Stock Offering to Advance Multikine Cancer Immunotherapy 1 - Minichart
CEL-SCI closes $2.5M stock offering at $1 per share By Investing.com - Investing.com South Africa
CEL-SCI (CVM) Advances Multikine for Head and Neck Cancer - GuruFocus
CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent - TradingView
CEL-SCI (NYSE American: CVM) prices $2.5M best-efforts stock offering - Stock Titan
CEL-SCI closes $2.5M stock offering at $1 per share - Investing.com
Cancer immunotherapy firm CEL-SCI raises $2.5M for Multikine development - Stock Titan
CEL-SCI Announces Closing of Offering - Yahoo Finance
CEL-SCI to begin confirmatory study for head and neck cancer drug - Investing.com
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy - Yahoo Finance
[424B5] CEL SCI CORP Prospectus Supplement (Debt Securities) - Stock Titan
CEL-SCI Corporation (CVM) Prices Public Offering, Shares Drop in Premarket - GuruFocus
CEL-SCI stock sale prices $2.5M to fund Multikine work - Stock Titan
1.84%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):